Differences in the length of gag proteins among different HIV type 1 subtypes

被引:11
作者
Holguín, A [1 ]
Alvarez, A [1 ]
Soriano, V [1 ]
机构
[1] Hosp Carlos 3, Dept Infect Dis, Madrid 28029, Spain
关键词
D O I
10.1089/aid.2005.21.886
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of HIV-1 subtype on Gag protein length was examined in 122 individuals infected with different HIV-1 clades. Except for the P1 protein, a wide variation in the Gag proteins length was noticed. P2 was significantly shorter in 68 non-B with respect to 54 subtype B viruses. Nearly 85% of subtype B gag sequences harbored P2 with 14 or more amino acid (aa) residues, while 75% of non-B subtypes had P2 with 13 or less aa (p < 0.0001). The P7 protein was one residue shorter in 64.2% of non-B specimens but only in 9.3% of subtype B isolates (p = 0.0001). Overall, the P6(gag) protein length was modified by the presence of insertions, deletions, and stop codons in 89 (73%) of the tested population, but was mainly dependent of changes in non-B compared to B viruses (97% vs. 42.6%, p < 0.0001). However, insertions at P6gag ( from 1 to 9 aa) were significantly more frequent in B than in non-B viruses (33.3% vs. 4.4%; p = 0.00002). Overall, conserved Gag residues and aa motifs, regardless of the genetic subtype, were 68.7% in P1, 54% in P7, 33.3% in P2, and 25% in P6gag proteins. In summary, length variation in Gag proteins is extensive across different HIV-1 subtypes, and could influence protein structure and function. The effect of Gag variation on the viral cycle among different HIV-1 clades needs to be further investigated.
引用
收藏
页码:886 / 893
页数:8
相关论文
共 42 条
[1]  
ADDURAHMAN S, 2004, J GEN VIROL, V85, P2903
[2]   A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa [J].
Baldrich-Rubio, E ;
Anagonou, S ;
Stirrups, K ;
Lafia, E ;
Candotti, D ;
Lee, H ;
Allain, JP .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :1095-1106
[3]   Polymorphism of HIV type 1 Gag p7/p1 and p1/p6 cleavage sites: Clinical significance and implications for resistance to protease inhibitors [J].
Bally, F ;
Martinez, R ;
Peters, S ;
Sudre, P ;
Telenti, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (13) :1209-1213
[4]   Natural variation in HIV-1 protease, gag p7 and p6, and protease cleavage sites within Gag/Pol polyproteins: Amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1 [J].
Barrie, KA ;
Perez, E ;
Lamers, SL ;
Farmerie, WG ;
Dunn, BM ;
Sleasman, JW ;
Goodenow, MM .
VIROLOGY, 1996, 219 (02) :407-416
[5]  
Craven RC, 1996, CURR TOP MICROBIOL, V214, P65
[6]   Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness? [J].
de Oliveira, T ;
Engelbrecht, S ;
van Rensburg, EJ ;
Gordon, M ;
Bishop, K ;
zur Megede, J ;
Barnett, SW ;
Cassol, S .
JOURNAL OF VIROLOGY, 2003, 77 (17) :9422-9430
[7]  
Descamps D, 1998, AIDS, V12, P1109
[8]   Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors [J].
Doyon, L ;
Croteau, G ;
Thibeault, D ;
Poulin, F ;
Pilote, L ;
Lamarre, D .
JOURNAL OF VIROLOGY, 1996, 70 (06) :3763-3769
[9]   The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: Possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site [J].
Feng, YX ;
Campbell, S ;
Harvin, D ;
Ehresmann, B ;
Ehresmann, C ;
Rein, A .
JOURNAL OF VIROLOGY, 1999, 73 (05) :4251-4256
[10]   HIV-1 nucleocapsid protein induces ''maturation'' of dimeric retroviral RNA in vitro [J].
Feng, YX ;
Copeland, TD ;
Henderson, LE ;
Gorelick, RJ ;
Bosche, WJ ;
Levin, JG ;
Rein, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7577-7581